Daily news email for February 17, 2012 | Click here for updated news
Biotechnology - Moreover Analysis of Relative Performance in the Biotechnology Industry for Shares of Incyte (INCY, ONXX, ALKS, SPPI, MITI)
Top 5 Companies in the Biotechnology Industry with the Best Relative Performance (CPHD, IMGN, HGSI, SGEN, RIGL)
NIH Translational Center Should Raise All Boats, BIO Says
Immunogen, inc. reports second quarter fiscal year 2012 financial results and provides quarterly update
Biotechnology to be 21st-century industry: Life Tech CEO
|
Burrill Report Will Obama's Budget Hinder Innovation
The Sinews of Safety
Obama Administration Boosts Alzheimer's Research Spending
FDA Unveils Biosimilars Guidance
Medical Device Firms Bring In the Bucks
|
CenterWatch - Clinical Trials Sanofi's $20 billion Genzyme buy could fuel a big pharma-biotechnology acquisition trend
New Quintiles initiative saves investigative sites the time, and cost, of patient recruitment advertising
Technology companies adapt interactive video concepts for clinical trial informed consent
CRI buys Lifetree, combining investigative sites on both coasts and across all trial phases
New $1b NIH center will tackle early-stage drug development to ease industry risk of failure
|
New York Times- Pharmaceuticals Diet Treatment, Already in Use, to Get F.D.A. Review
Counterfeit Doses of Avastin Distributed in the U.S.
Twin Births in the U.S., Like Never Before
Joint Effort Announced Against Tropical Diseases
Supply of Methotrexate, a Cancer Drug, May Run Out Soon
|
OnBioVC Arteaus Therapeutics, LLC: Series A $18M
100Plus, Inc.: Series A $1.3M
EndoEvolution, LLC: Series B $3.3M
Cleave Biosciences, Inc.: Series A $44M
Firefly BioWorks, Inc.: Series A $2M
|
Outsourcing-Pharma An experienced CMO is key to successful biologics development says Cobra Biologics
Parexel discusses transdermal drug delivery techs
Sponsors and CROs differ on perception of service quality, says the Avoca Group
Recipharm CEO talks CMO sector recovery and Asian plans
Covance adding mass spec for biosimilars
|